When and how to use serum tumor markers in clinical practice

Article Type

Article

Changed

Mon, 04/15/2019 - 09:09

Display Headline

When and how to use serum tumor markers in clinical practice

Author(s)

Maurie Markman, MD

Article PDF

media_81cc108_ccjm64_1-0027.pdf

Author and Disclosure Information

Maurie Markman, MD
Chairman of the Department of Hematology/Medical Oncology at the Cleveland Clinic, and an associate editor of the Cleveland Clinic Journal of Medicine.

Address: Maurie Markman, MD, Department of Hematology/Medical Oncology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Issue

Cleveland Clinic Journal of Medicine - 64(1)

Publications

Cleveland Clinic Journal of Medicine

Page Number

27-29

Sections

Reviews

Author(s)

Maurie Markman, MD

Author(s)

Maurie Markman, MD

Author and Disclosure Information

Maurie Markman, MD
Chairman of the Department of Hematology/Medical Oncology at the Cleveland Clinic, and an associate editor of the Cleveland Clinic Journal of Medicine.

Address: Maurie Markman, MD, Department of Hematology/Medical Oncology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Maurie Markman, MD
Chairman of the Department of Hematology/Medical Oncology at the Cleveland Clinic, and an associate editor of the Cleveland Clinic Journal of Medicine.

Address: Maurie Markman, MD, Department of Hematology/Medical Oncology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF

media_81cc108_ccjm64_1-0027.pdf

Article PDF

media_81cc108_ccjm64_1-0027.pdf

Issue

Cleveland Clinic Journal of Medicine - 64(1)

Issue

Cleveland Clinic Journal of Medicine - 64(1)

Page Number

27-29

Page Number